Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yajie Xiao

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Entropy (Basel, Switzerland)|July 8, 2023
Two-Level Finite Element Iterative Algorithm Based on Stabilized Method for the Stationary Incompressible MagnetohydrodynamicsQili Tang, Min Hou, Yajie Xiao, et al.
Pharmacogenomics|December 21, 2012
Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemiaMiao Hu, Valiant Wl Mak, Yajie Xiao, et al.
Frontiers in Genetics|October 31, 2022
Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinomaYanju Lv, Yajie Xiao, Xiaoli Cui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2021
A Novel Intergenic Region Between KLHL31 and LRRC1-ALK Exon 20 Fusion Variant in Advanced Lung Adenocarcinoma and its Remarkable Response to ALK InhibitorHuibing Qiu, Qianwen Li, Yajie Xiao, et al.
Briefings in Bioinformatics|July 15, 2020
Investigations of sequencing data and sample type on HLA class Ia typing with different computational toolsJian Yi, Longyun Chen, Yajie Xiao, et al.
Anti-Cancer Drugs|May 25, 2023
Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant ( L833V / H835L ) lung adenocarcinoma patient: a case reportZhilin Luo, Chengwen Luo, Runquan Zhou, et al.
Frontiers in Immunology|January 24, 2025
First-line combination therapy of immunotherapy plus anti-angiogenic drug for thoracic SMARCA4-deficient undifferentiated tumors in AIDS: a case report and review of the literatureXiaoling Wei, Xiangju Xing, Wei Yao, et al.
Frontiers in Cell and Developmental Biology|March 4, 2022
Expression Patterns of Glycosylation Regulators Define Tumor Microenvironment and Immunotherapy in Gastric CancerFang Li, Kaibin Huang, Chaohu Pan, et al.
Journal of Oncology|August 12, 2022
Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic ModelsHuikai Li, Han Mu, Yajie Xiao, et al.
Frontiers in Oncology|August 18, 2022
Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case reportHui Li, Yixiao Deng, Bin Chen, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Entropy (Basel, Switzerland)|July 8, 2023
Two-Level Finite Element Iterative Algorithm Based on Stabilized Method for the Stationary Incompressible MagnetohydrodynamicsQili Tang, Min Hou, Yajie Xiao, et al.
Pharmacogenomics|December 21, 2012
Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemiaMiao Hu, Valiant Wl Mak, Yajie Xiao, et al.
Frontiers in Genetics|October 31, 2022
Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinomaYanju Lv, Yajie Xiao, Xiaoli Cui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2021
A Novel Intergenic Region Between KLHL31 and LRRC1-ALK Exon 20 Fusion Variant in Advanced Lung Adenocarcinoma and its Remarkable Response to ALK InhibitorHuibing Qiu, Qianwen Li, Yajie Xiao, et al.
Briefings in Bioinformatics|July 15, 2020
Investigations of sequencing data and sample type on HLA class Ia typing with different computational toolsJian Yi, Longyun Chen, Yajie Xiao, et al.
Anti-Cancer Drugs|May 25, 2023
Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant ( L833V / H835L ) lung adenocarcinoma patient: a case reportZhilin Luo, Chengwen Luo, Runquan Zhou, et al.
Frontiers in Immunology|January 24, 2025
First-line combination therapy of immunotherapy plus anti-angiogenic drug for thoracic SMARCA4-deficient undifferentiated tumors in AIDS: a case report and review of the literatureXiaoling Wei, Xiangju Xing, Wei Yao, et al.
Frontiers in Cell and Developmental Biology|March 4, 2022
Expression Patterns of Glycosylation Regulators Define Tumor Microenvironment and Immunotherapy in Gastric CancerFang Li, Kaibin Huang, Chaohu Pan, et al.
Journal of Oncology|August 12, 2022
Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic ModelsHuikai Li, Han Mu, Yajie Xiao, et al.
Frontiers in Oncology|August 18, 2022
Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case reportHui Li, Yixiao Deng, Bin Chen, et al.
Pageof 4